119 related articles for article (PubMed ID: 2213829)
1. Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates.
Hill CL; Weeks MS; Schinazi RF
J Med Chem; 1990 Oct; 33(10):2767-72. PubMed ID: 2213829
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity.
Inouye Y; Fujimoto Y; Sugiyama M; Yoshida T; Yamase T
Biol Pharm Bull; 1995 Jul; 18(7):996-1000. PubMed ID: 7581257
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase.
Inouye Y; Tokutake Y; Kunihara J; Yoshida T; Yamase T; Nakata A; Nakamura S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):805-7. PubMed ID: 1377101
[TBL] [Abstract][Full Text] [Related]
4. Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates.
Shigeta S; Mori S; Kodama E; Kodama J; Takahashi K; Yamase T
Antiviral Res; 2003 May; 58(3):265-71. PubMed ID: 12767474
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biological activity of a new potent class of anti-HIV agents, the peroxoniobium-substituted heteropolytungstates.
Kim GS; Judd DA; Hill CL; Schinazi RF
J Med Chem; 1994 Mar; 37(6):816-20. PubMed ID: 7511692
[TBL] [Abstract][Full Text] [Related]
6. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of replication of human immunodeficiency virus by a heteropolyoxotungstate (PM-19).
Inouye Y; Take Y; Tokutake Y; Yoshida T; Yamamoto A; Yamase T; Nakamura S
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):285-7. PubMed ID: 2337949
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular mechanisms of antiretroviral effects of HPA23.
Dormont D; Yeramian P; Lambert P; Spire B; Daveloose D; Barre-Sinoussi FC; Chermann JC
Cancer Detect Prev; 1988; 12(1-6):181-94. PubMed ID: 2460236
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and anti-human immunodeficiency virus activity of water-soluble salts of polyoxotungstate anions with covalently attached organic groups.
Weeks MS; Hill CL; Schinazi RF
J Med Chem; 1992 Apr; 35(7):1216-21. PubMed ID: 1373190
[TBL] [Abstract][Full Text] [Related]
10. Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases.
Herve M; Sinoussi-Barre F; Chermann JC; Herve G; Jasmin C
Biochem Biophys Res Commun; 1983 Oct; 116(1):222-9. PubMed ID: 6196027
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial Activity of Polyoxometalates Against
Gumerova NI; Al-Sayed E; Krivosudský L; Čipčić-Paljetak H; Verbanac D; Rompel A
Front Chem; 2018; 6():336. PubMed ID: 30155460
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of Krebs-type polyoxometalates with N,O-chelating ligands: a systematic study.
Artetxe B; Reinoso S; San Felices L; Vitoria P; Pache A; Martín-Caballero J; Gutiérrez-Zorrilla JM
Inorg Chem; 2015 Jan; 54(1):241-52. PubMed ID: 25397905
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicity.
Escuret V; Aucagne V; Joubert N; Durantel D; Rapp KL; Schinazi RF; Zoulim F; Agrofoglio LA
Bioorg Med Chem; 2005 Nov; 13(21):6015-24. PubMed ID: 16023859
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of highly negative charged polyoxotungstates, K27[KAs4W40O140] and K18[KSb9W21O86], and Keggin-structural polyoxotungstates against Helicobacter pylori.
Inoue M; Segawa K; Matsunaga S; Matsumoto N; Oda M; Yamase T
J Inorg Biochem; 2005 May; 99(5):1023-31. PubMed ID: 15833325
[TBL] [Abstract][Full Text] [Related]
16. Review of the effects of pH on the synthesis of heteropoly tungstate anions.
Wasfi SH; Johnson WL
Front Biosci; 2003 Sep; 8():s936-44. PubMed ID: 12957867
[TBL] [Abstract][Full Text] [Related]
17. Transformation from [W6O19](2-) to [W6O22](8-) stabilized by Cu(II) complexation.
Cui FY; Huang KL; Ma XY; Li C; Han ZG; Gao YZ; Liu X; Chi YN; Hu CW
Dalton Trans; 2010 Jun; 39(21):5080-3. PubMed ID: 20422077
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of pyridinium polyoxometalates as anti-HIV-1 agents.
Wang S; Sun W; Hu Q; Yan H; Zeng Y
Bioorg Med Chem Lett; 2017 Jun; 27(11):2357-2359. PubMed ID: 28431877
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TIBO) derivatives.
Kukla MJ; Breslin HJ; Pauwels R; Fedde CL; Miranda M; Scott MK; Sherrill RG; Raeymaekers A; Van Gelder J; Andries K
J Med Chem; 1991 Feb; 34(2):746-51. PubMed ID: 1995896
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of novel thymidine analogs as antitumor and antiviral agents.
Chen X; Bastow K; Goz B; Kucera LS; Morris-Natschke SL; Ishaq KS
J Med Chem; 1996 Aug; 39(17):3412-7. PubMed ID: 8765526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
